Filter by: Subject

Filter by: Subject

Results Per Page:

Positron emission tomography (PET) (9)
SDG-03: Good health and well-being (6)
Prostate carcinoma (5)
Prostate-specific membrane antigen (PSMA) (4)
Breast cancer (3)
PET/CT (3)
PSA response (3)
225Ac-PSMA-617 (2)
68Ga-PSMA (2)
Cervical cancer (2)
Computed tomography (CT) (2)
Hypoxia (2)
Immunohistochemistry (2)
Metastatic castration-resistant prostate cancer (mCRPC) (2)
Positron emission tomography/computed tomography (PET/CT) (2)
Principal component analysis (PCA) (2)
Radiomics (2)
Somatropin (2)
Therapy response (2)
Tuberculosis (TB) (2)
18F-FDG (1)
18F-fuorodeoxyglucose (FDG) (1)
225Ac-PSMA (1)
68Ga-citrate (1)
68Ga-Nitroimidazole (1)
[68Ga]Ga-FAPI PET/CT (1)
Androgen deprivation treatment (ADT) (1)
Angiogenesis (1)
Behandlung (1)
Benign vs. malignant (1)
Bins (1)
Bioassay (1)
Biomaterials (1)
Black South-African (BSAs) (1)
Blood–brain barrier (BBB) (1)
Bone SPECT-CT (1)
Capillary electrophoresis–mass spectrometry (CE-MS) (1)
Carcinoma, squamous cell (1)
Characterization (1)
Chelation (1)
Chemical analysis (1)
Chemical modification (1)
Chromatography (1)
Colon cancer (1)
Colorectal cancer (1)
Computerized tomography (CT) (1)
Computerized tomography' (CT) (1)
Cryptic peptides (1)
Dichroism (1)
Drug products (1)
FAPI tumor volume (FAPI-TV) (1)
FDG PET/CT (1)
FDG-PET (1)
FDG-PET imaging (1)
Fludeoxyglucose (FDG) (1)
Fluorine-18-Fluorodeoxyglucose (FDG) (1)
Fluorodeoxyglucose F18 (1)
Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) (1)
Fluorodeoxyglucose-positron emission tomography (FDG PET) (1)
Functional characterization (1)
Gastro-intestinal cancer (1)
GHR bioassay (1)
Growth hormone receptor (GHR) (1)
Health sciences article SDG-03 (1)
Highly active antiretroviral therapy (HAART) (1)
HIV infection (1)
HIV infections (1)
Human growth hormone (1)
Human immunodeficiency virus (HIV) (1)
Human microbiome (1)
Hypoxia inducible factor-1 (HIF-1) (1)
Hypoxia-inducible factor-1alpha (HIF-1) (1)
Hypoxic tumor volume (HTV) (1)
Immunohistochemistry (IHC) (1)
Inherent complexity (1)
Intra-tumoral heterogeneity (1)
Isomers (1)
LIFEx software (1)
Lipodystrophy (1)
Liquid chromatography–mass spectrometry (LC-MS) (1)